🔗 Permalink

Assignee profile:

Xigen, S.A.

City:

Lausanne

Country:

Switzerland

Published Applications:

Last publication date:

2014-02-27

Patent Grants:

Last grant date:

2013-10-29

Top Inventors for applications by Xigen, S.A.

These are the the leading inventors for applications assigned to Xigen, S.A.:

Christophe BONNY 7 Lausanne, Switzerland
Christophe BONNY 4 Morges, Switzerland
Didier Coquoz 1 St. Sulpice, Switzerland

Recent patent applications by Xigen, S.A.

Xigen, S.A. based in Lausanne, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-02-27

US20140057834A1

Chemistry; metallurgy

Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway

#2 | 2013-03-07 ✅ Patent 8,569,447 granted on 2013-10-29

US20130059798A1

Chemistry; metallurgy

Cell-permeable peptide inhibitors of the JNK signal transduction pathway

#3 | 2012-05-22 ✅ Patent 8,183,339 granted on 2012-05-22

US10110430

Cell-permeable peptide inhibitors of the JNK signal transduction pathway

#4 | 2010-09-28 ✅ Patent 7,803,749 granted on 2010-09-28

US10340458

Peptide inhibitors of MKK7 kinase binding to insulin binding proteins

#5 | 2010-03-04 ✅ Patent 7,943,574 granted on 2011-05-17

US20100056459A1

Chemistry; metallurgy

Cell-permeable peptide inhibitors of the JNK signal transduction pathway

#6 | 2009-03-12 ✅ Patent 8,236,924 granted on 2012-08-07

US20090069234A1

Chemistry; metallurgy

Cell-permeable peptide inhibitors of the JNK signal transduction pathway

#7 | 2008-11-06

US20080274956A1

Chemistry; metallurgy

Fusion Protein Comprising a Bh3-Domain of a Bh3-Only Protein

#8 | 2007-03-15 ✅ Patent 8,080,517 granted on 2011-12-20

US20070060514A1

Chemistry; metallurgy

Cell-permeable peptide inhibitors of the JNK signal transduction pathway

#9 | 2006-09-14 ✅ Patent 7,538,091 granted on 2009-05-26

US20060205665A1

Chemistry; metallurgy

Intracellular delivery of biological effectors

#10 | 2005-05-19 ✅ Patent 7,635,681 granted on 2009-12-22

US20050106695A1

Chemistry; metallurgy

Cell-permeable peptide inhibitors of the JNK signal transduction pathway

AssigneeID:

56567 ⎘